Enoxaparin can be used safely in patients with severe thrombocytopenia due to intensive chemotherapy regimens.
about
Blue toes and a new pair of shoes--challenges in diagnosis and treatment of acute myelogenous leukemia.Antithrombotic therapy in patients with thrombocytopenic cancer: outcomes associated with reduced-dose, low-molecular-weight heparin during hospitalization.Prevention of venous thromboembolism in hospitalized medical cancer patients: guidance from the SSC of the ISTH.Management and outcomes of cancer-associated venous thromboembolism in patients with concomitant thrombocytopenia: a retrospective cohort study.Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 1: prophylaxis.Venous thromboembolism in patients with hematologic malignancy and thrombocytopenia.Aspirin Is Associated with Improved Survival in Severely Thrombocytopenic Cancer Patients with Acute Myocardial Infarction.Enoxaparin dose reduction for thrombocytopenia in patients with cancer: a quality assessment study.Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohort.Pathophysiology and management of thrombosis in cancer: 150 years of progress.L-asparaginase and venous thromboembolism in acute lymphocytic leukemiaManagement of venous thromboembolism in patients with acute leukemia at high bleeding risk: a multi-center study.Antithrombotic therapy for prophylaxis and treatment of venous thromboembolism in patients with cancer: review of the literature on current practice and emerging options.Management of anticoagulation for cancer-associated thrombosis in patients with thrombocytopenia: A systematic review
P2860
Q33409558-AA4AB295-565F-4D08-AE90-BBE32DCBDACEQ33416407-F0C84E5E-87DB-4CE9-B06F-3F6B4A6B3866Q33416926-A871AFDD-ADA6-4643-9D15-AFC7DF3CBD31Q33417504-52B1EDB6-9ACF-4A5B-8865-C2A1075B3275Q33422297-C00EBC24-2207-4C66-8E77-86ED6D4764D7Q33434346-1033CB60-971C-4B5D-9986-F132EBE6F31CQ33438981-01474137-2DC9-4FAD-BBEE-AA22D2853305Q33439387-66767A8D-20D3-4D0D-8516-0D61A582F57EQ33440816-BF23C79C-ACC3-4663-8539-7FC2D8D67811Q38084608-2EC968D4-CCE8-4451-8E62-948B781B1F16Q38566744-B57F8E02-7F26-4410-B415-6D27241F1E24Q41759311-19F0A290-A35A-4E91-AB8D-2C5FDEA806F6Q55364590-184E28D7-CF43-479B-8A7D-0F8E0C1123B2Q57825250-109FEEB2-AD1B-41CE-BCEC-0E0EA15F9B93
P2860
Enoxaparin can be used safely in patients with severe thrombocytopenia due to intensive chemotherapy regimens.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Enoxaparin can be used safely ...... tensive chemotherapy regimens.
@ast
Enoxaparin can be used safely ...... tensive chemotherapy regimens.
@en
type
label
Enoxaparin can be used safely ...... tensive chemotherapy regimens.
@ast
Enoxaparin can be used safely ...... tensive chemotherapy regimens.
@en
prefLabel
Enoxaparin can be used safely ...... tensive chemotherapy regimens.
@ast
Enoxaparin can be used safely ...... tensive chemotherapy regimens.
@en
P2093
P2860
P1433
P1476
Enoxaparin can be used safely ...... tensive chemotherapy regimens.
@en
P2093
Amiram Eldor
Ella Naparstek
Ilya Kirgner
Mudi Misgav
Ofira Ben-Tal
Yair Herishanu
P2860
P304
P356
10.1080/10428190410001663671
P577
2004-07-01T00:00:00Z